SCHEMBL125090

SCHEMBL125090

[2H]Bc1ccc2ccccc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 7/20 0.42
CYP1A2 P05177 5/20 0.42
ALDH1A1 P00352 3/20 0.42
CYP3A4 P08684 3/20 0.42
HSD17B10 Q99714 3/20 0.42
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42
ALOX12 P18054 1/20 0.40
CES2 O00748 1/20 0.38
CES1 P23141 1/20 0.38
GSTP1 P09211 1/20 0.37
HPGD P15428 1/20 0.37
RELA Q04206 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
HIF1A Q16665 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL319839 0.81 CYP2A6 (0.48) CYP2A6CYP1A2ALDH1A1CYP3A4HSD17B10
SCHEMBL11959837 0.74 ALDH1A1 (0.50) CYP2A6CYP1A2ALDH1A1CYP3A4HSD17B10
SCHEMBL14983311 0.74 ALDH1A1 (0.50) CYP2A6CYP1A2ALDH1A1CYP3A4HSD17B10
SCHEMBL19336401 0.73 ESR1 (0.56) CYP1A2ALDH1A1CYP3A4HSD17B10CA1
SCHEMBL12044703 0.73 ESR1 (0.56) CYP1A2ALDH1A1CYP3A4HSD17B10CA1
Naphthalene SCHEMBL2263115 0.71 CYP2A6 (0.67) CYP2A6CYP1A2ALDH1A1CYP3A4HSD17B10
SCHEMBL14304431 0.68 CYP2A6 (0.37) CYP2A6CYP1A2ALDH1A1CYP3A4HSD17B10
Anthracene SCHEMBL3187575 0.67 CYP2A6 (0.73) CYP2A6CYP1A2ALDH1A1CYP3A4HSD17B10
Anthracene SCHEMBL5713428 0.67 CYP2A6 (0.73) CYP2A6CYP1A2ALDH1A1CYP3A4HSD17B10
SCHEMBL12626674 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120059163-A1 Non-linear opticaly active molecules, their synthesis, and use OPTIMER PHOTONICS, INC. (US) 2012-03-08 US disclosed
US-20080004415-A1 Non-linear optically active molecules, their synthesis, and use OPTIMER PHOTONICS, INC. (US) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120059163-A1 Non-linear opticaly active molecules, their synthesis, and use INCENP, CYBA, ADCY5 CYP2A6 1574/4885CYP1A2 1562/4885ALDH1A1 371/4885
US-20080004415-A1 Non-linear optically active molecules, their synthesis, and use INCENP, CYBA, PAICS CYP2A6 1513/4885CYP1A2 1595/4885ALDH1A1 378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.